Kanāda - angļu - Health Canada

sandoz canada incorporated - methylprednisolone acetate - suspension - 80mg - methylprednisolone acetate 80mg - adrenals

Kanāda - angļu - Health Canada

sandoz canada incorporated - methylprednisolone acetate - suspension - 40mg - methylprednisolone acetate 40mg - adrenals

Kanāda - angļu - Health Canada

sandoz canada incorporated - methylprednisolone acetate - suspension - 80mg - methylprednisolone acetate 80mg - adrenals

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

kaiser foundation hospitals - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 16 mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

physicians total care, inc. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone tablets are indicated in the following conditions: - endocrine disorders : primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoid where applicable; in infancy, mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia hypercalcemia associated with cancer nonsuppurative thyroiditis - rheumatic disorders : as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis - collagen diseases : during an exacerbation or as maintenance therapy in selec

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

stat rx usa llc - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone tablets are indicated in the following conditions: 1.endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer 2.rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode orexacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis 3.collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus s

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - methylprednisolone 4 mg - tablet - 4 mg - methylprednisolone 4 mg - methylprednisolone

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - methylprednisolone 16 mg - tablet - 16 mg - methylprednisolone 16 mg - methylprednisolone

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone tablets are indicated in the following conditions:   primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic cardit

Kanāda - angļu - Health Canada

teva canada limited - methylprednisolone (methylprednisolone sodium succinate) - powder for solution - 5g - methylprednisolone (methylprednisolone sodium succinate) 5g - adrenals